Evidence map›Paper›PMID 41940608›Full record

ArticleEpileptic disorders : international epilepsy journal with videotape2026

The second unprovoked seizure in a cohort of treated patients with a first unprovoked seizure.

Revital Gandelman-Marton, Jacques Theitler

Abstract read
In one paragraph

Article in Epileptic disorders : international epilepsy journal with videotape, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Revital Gandelman-MartonNeurology Department, Shamir-Assaf Harofeh Medical Center, Zerifin, Israel.ORCID https://orcid.org/0000-0002-4492-1739
Jacques TheitlerNeurology Department, Shamir-Assaf Harofeh Medical Center, Zerifin, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the rate of a second unprovoked seizure in antiseizure medications (ASMs)-treated patients following a first unprovoked seizure and to identify potential risk factors associated with its occurrence.

methodsA retrospective review of the computerized database and the medical records of all the patients who presented to our outpatient epilepsy clinic following admission and ASM initiation due to a first unprovoked seizure during a decade (2012-2021).

resultsThe study group included 60 patients aged 18-84 years (mean: 40.8 years), 35 (58.3%) men. A second unprovoked seizure occurred in 43% of the patients at last observation. Seventy-five percent of the recurrences occurred at 3 years. Patients with a second unprovoked seizure were younger (32.9 vs. 46.9 years) (p = 0.010) and more likely to be women (64% vs. 28.6%) (p = 0.009) compared to patients without recurrent seizures. SIGNIFICANCE: Women and younger patients may deserve closer monitoring following a first unprovoked seizure. Further studies are needed to assess the efficacy of specific treatment strategies among all people with a first unprovoked seizure, with emphasis on younger adults and especially women.

Indexed as

AnticonvulsantsEpilepsySeizuresAdolescentAdultAgedAged, 80 and overAge FactorsFemaleHumansMaleMiddle AgedRecurrenceRetrospective StudiesRisk FactorsYoung AdultAnticonvulsantsantiseizure medicationssecond unprovoked seizure

Identifiers

PMID41940608
PMCPMC13499269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.